IL285214A - Vortex mixers and associated methods, systems, and apparatuses thereof - Google Patents

Vortex mixers and associated methods, systems, and apparatuses thereof

Info

Publication number
IL285214A
IL285214A IL285214A IL28521421A IL285214A IL 285214 A IL285214 A IL 285214A IL 285214 A IL285214 A IL 285214A IL 28521421 A IL28521421 A IL 28521421A IL 285214 A IL285214 A IL 285214A
Authority
IL
Israel
Prior art keywords
apparatuses
systems
associated methods
vortex mixers
mixers
Prior art date
Application number
IL285214A
Other languages
Hebrew (he)
Original Assignee
Modernatx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Modernatx Inc filed Critical Modernatx Inc
Publication of IL285214A publication Critical patent/IL285214A/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/10Mixing by creating a vortex flow, e.g. by tangential introduction of flow components
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/10Mixing by creating a vortex flow, e.g. by tangential introduction of flow components
    • B01F25/104Mixing by creating a vortex flow, e.g. by tangential introduction of flow components characterised by the arrangement of the discharge opening
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F31/00Mixers with shaking, oscillating, or vibrating mechanisms
    • B01F31/20Mixing the contents of independent containers, e.g. test tubes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00Other mixers; Mixing plants; Combinations of mixers
    • B01F33/30Micromixers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00Other mixers; Mixing plants; Combinations of mixers
    • B01F33/80Mixing plants; Combinations of mixers
    • B01F33/81Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles
    • B01F33/811Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles in two or more consecutive, i.e. successive, mixing receptacles or being consecutively arranged
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00Other mixers; Mixing plants; Combinations of mixers
    • B01F33/80Mixing plants; Combinations of mixers
    • B01F33/81Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles
    • B01F33/813Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles mixing simultaneously in two or more mixing receptacles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2101/00Mixing characterised by the nature of the mixed materials or by the application field
    • B01F2101/22Mixing of ingredients for pharmaceutical or medical compositions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mixers Of The Rotary Stirring Type (AREA)
IL285214A 2019-01-31 2021-07-29 Vortex mixers and associated methods, systems, and apparatuses thereof IL285214A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962799636P 2019-01-31 2019-01-31
US201962886592P 2019-08-14 2019-08-14
PCT/US2020/016150 WO2020160430A1 (en) 2019-01-31 2020-01-31 Vortex mixers and associated methods, systems, and apparatuses thereof

Publications (1)

Publication Number Publication Date
IL285214A true IL285214A (en) 2021-09-30

Family

ID=69740760

Family Applications (1)

Application Number Title Priority Date Filing Date
IL285214A IL285214A (en) 2019-01-31 2021-07-29 Vortex mixers and associated methods, systems, and apparatuses thereof

Country Status (12)

Country Link
US (1) US20220126244A1 (en)
EP (1) EP3917656A1 (en)
JP (1) JP7545395B2 (en)
KR (1) KR20210133218A (en)
CN (1) CN113710353A (en)
AU (1) AU2020214425A1 (en)
BR (1) BR112021014909A2 (en)
CA (1) CA3128488A1 (en)
IL (1) IL285214A (en)
MX (1) MX2021009236A (en)
SG (1) SG11202108098QA (en)
WO (1) WO2020160430A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102340408B1 (en) * 2020-08-05 2021-12-16 건국대학교 산학협력단 Container holding device
CN113908744A (en) * 2021-11-08 2022-01-11 常州大学 Microfluidic mixer and application thereof
WO2023193002A1 (en) * 2022-04-01 2023-10-05 Modernatx, Inc. Cross mixers for lipid nanoparticle production, and methods of operating the same
WO2024091918A2 (en) * 2022-10-25 2024-05-02 Modernatx, Inc. Methods of lipid nanoparticle production in cross-mixers
JP7457194B1 (en) 2023-08-18 2024-03-27 旭有機材株式会社 Vortex fluid mixer
JP7457193B1 (en) 2023-08-18 2024-03-27 旭有機材株式会社 Vortex fluid mixer

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013497A (en) * 1988-03-03 1991-05-07 Micro-Pak, Inc. Method and apparatus for producing lipid vesicles
US5405497A (en) * 1990-08-28 1995-04-11 Kamyr, Inc. Method of chemically reacting a liquid with a gas in a vortex
GB9320455D0 (en) * 1993-10-05 1993-11-24 Atomic Energy Authority Uk Vortex mixer
US6310197B1 (en) 1997-11-12 2001-10-30 The Brigham And Women's Hospital, Inc. Translation enhancer element of the human amyloid precursor protein gene
EP1259602A1 (en) 2000-01-28 2002-11-27 The Scripps Research Institute Methods of identifying synthetic transcriptional and translational regulatory elements, and compositions relating to same
US7468275B2 (en) 2000-01-28 2008-12-23 The Scripps Research Institute Synthetic internal ribosome entry sites and methods of identifying same
WO2001089675A2 (en) * 2000-05-24 2001-11-29 Micronics, Inc. Jet vortex mixer
EP2305699B1 (en) 2001-06-05 2014-08-13 CureVac GmbH Stabilised mRNA with increased G/C content which is optimised for translation in its coded areas for the vaccination against sleeping sickness, leishmaniosis and toxoplasmosis
DE10162480A1 (en) 2001-12-19 2003-08-07 Ingmar Hoerr The application of mRNA for use as a therapeutic agent against tumor diseases
DE10229872A1 (en) 2002-07-03 2004-01-29 Curevac Gmbh Immune stimulation through chemically modified RNA
DE10335833A1 (en) 2003-08-05 2005-03-03 Curevac Gmbh Transfection of blood cells with mRNA for immune stimulation and gene therapy
DE102004042546A1 (en) 2004-09-02 2006-03-09 Curevac Gmbh Combination therapy for immune stimulation
DE102005023170A1 (en) 2005-05-19 2006-11-23 Curevac Gmbh Optimized formulation for mRNA
AU2006283077B2 (en) 2005-08-24 2012-06-28 The Scripps Research Institute Translation Enhancer-Element dependent vector systems
DE102006007433A1 (en) 2006-02-17 2007-08-23 Curevac Gmbh Immunostimulant adjuvant useful in vaccines against cancer or infectious diseases comprises a lipid-modified nucleic acid
EP2049665A2 (en) 2006-07-28 2009-04-22 Applera Corporation Dinucleotide mrna cap analogs
EP2046954A2 (en) 2006-07-31 2009-04-15 Curevac GmbH NUCLEIC ACID OF FORMULA (I): GIXmGn, OR (II): CIXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT
JP5030520B2 (en) 2006-09-29 2012-09-19 富士フイルム株式会社 Fluid mixing method and microdevice
DE102006051516A1 (en) 2006-10-31 2008-05-08 Curevac Gmbh (Base) modified RNA to increase the expression of a protein
DE102006061015A1 (en) 2006-12-22 2008-06-26 Curevac Gmbh Process for the purification of RNA on a preparative scale by HPLC
DE102007001370A1 (en) 2007-01-09 2008-07-10 Curevac Gmbh RNA-encoded antibodies
WO2008127688A1 (en) 2007-04-13 2008-10-23 Hart Communication Foundation Synchronizing timeslots in a wireless communication protocol
WO2009030254A1 (en) 2007-09-04 2009-03-12 Curevac Gmbh Complexes of rna and cationic peptides for transfection and for immunostimulation
CA2904904A1 (en) 2007-12-11 2009-06-18 The Scripps Research Institute Compositions and methods related to mrna translational enhancer elements
AU2009210266B2 (en) 2008-01-31 2015-01-29 CureVac SE Nucleic acids comprising formula (NuGlXmGmGnNv)a and derivatives thereof as an immunostimulating agents/adjuvants
DE102008009199A1 (en) * 2008-02-15 2009-08-27 Forschungszentrum Karlsruhe Gmbh Reaction mixer system for mixing and chemical reaction of at least two fluids
WO2009127230A1 (en) 2008-04-16 2009-10-22 Curevac Gmbh MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION
JP4798174B2 (en) * 2008-05-21 2011-10-19 株式会社日立プラントテクノロジー Emulsifying device
PL215513B1 (en) 2008-06-06 2013-12-31 Univ Warszawski New borane phosphate analogs of dinucleotides, their application, RNA particle, method of obtaining RNA and method of obtaining peptides or protein
WO2010037408A1 (en) 2008-09-30 2010-04-08 Curevac Gmbh Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
WO2010088927A1 (en) 2009-02-09 2010-08-12 Curevac Gmbh Use of pei for the improvement of endosomal release and expression of transfected nucleic acids, complexed with cationic or polycationic compounds
HUE056773T2 (en) 2009-06-10 2022-03-28 Arbutus Biopharma Corp Improved lipid formulation
EP2281579A1 (en) 2009-08-05 2011-02-09 BioNTech AG Vaccine composition comprising 5'-Cap modified RNA
US20110053829A1 (en) 2009-09-03 2011-03-03 Curevac Gmbh Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
KR101148080B1 (en) * 2009-12-07 2012-06-13 (주)인사이드밸류 Apparatus for mixing fluids
WO2011069529A1 (en) 2009-12-09 2011-06-16 Curevac Gmbh Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids
WO2011127255A1 (en) * 2010-04-08 2011-10-13 Merck Sharp & Dohme Corp. Preparation of lipid nanoparticles
EP2387999A1 (en) 2010-05-21 2011-11-23 CureVac GmbH Histidine-containing solution for transfection and/or injection of nucleic acids and uses thereof
WO2012009644A2 (en) 2010-07-16 2012-01-19 Arizona Board Of Regents Methods to identify synthetic and natural rna elements that enhance protein translation
DK2449113T3 (en) 2010-07-30 2016-01-11 Curevac Ag Complex formation of nucleic acids with the disulfide cross-linked cationic components for transfection and immunostimulation
WO2012019630A1 (en) 2010-08-13 2012-02-16 Curevac Gmbh Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein
WO2012089225A1 (en) 2010-12-29 2012-07-05 Curevac Gmbh Combination of vaccination and inhibition of mhc class i restricted antigen presentation
EP3202760B1 (en) 2011-01-11 2019-08-21 Alnylam Pharmaceuticals, Inc. Pegylated lipids and their use for drug delivery
WO2012116715A1 (en) 2011-03-02 2012-09-07 Curevac Gmbh Vaccination in newborns and infants
WO2012113413A1 (en) 2011-02-21 2012-08-30 Curevac Gmbh Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged with disulfide-linked polyethyleneglycol/peptide conjugates
WO2012116714A1 (en) 2011-03-02 2012-09-07 Curevac Gmbh Vaccination in elderly patients
WO2013103659A1 (en) 2012-01-04 2013-07-11 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Stabilizing rna by incorporating chain-terminating nucleosides at the 3'-terminus
EP2623121A1 (en) 2012-01-31 2013-08-07 Bayer Innovation GmbH Pharmaceutical composition comprising a polymeric carrier cargo complex and an antigen
WO2013113325A1 (en) 2012-01-31 2013-08-08 Curevac Gmbh Negatively charged nucleic acid comprising complexes for immunostimulation
WO2013113326A1 (en) 2012-01-31 2013-08-08 Curevac Gmbh Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
WO2013120499A1 (en) 2012-02-15 2013-08-22 Curevac Gmbh Nucleic acid comprising or coding for a histone stem-loop and a poly (a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
WO2013120498A1 (en) 2012-02-15 2013-08-22 Curevac Gmbh Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded allergenic antigen or an autoimmune self-antigen
WO2013120497A1 (en) 2012-02-15 2013-08-22 Curevac Gmbh Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
WO2013120500A1 (en) 2012-02-15 2013-08-22 Curevac Gmbh Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen
JP6301906B2 (en) 2012-03-27 2018-03-28 キュアバック アーゲー Artificial nucleic acid molecule containing 5 'TOPUTR
CN104220599A (en) 2012-03-27 2014-12-17 库瑞瓦格有限责任公司 Artificial nucleic acid molecules
CA2859452C (en) 2012-03-27 2021-12-21 Curevac Gmbh Artificial nucleic acid molecules for improved protein or peptide expression
WO2013174409A1 (en) 2012-05-25 2013-11-28 Curevac Gmbh Reversible immobilization and/or controlled release of nucleic acid containing nanoparticles by (biodegradable) polymer coatings
SG11201506052PA (en) 2013-02-22 2015-09-29 Curevac Gmbh Combination of vaccination and inhibition of the pd-1 pathway
WO2015002667A1 (en) 2013-07-01 2015-01-08 Myq, Inc. A location regulated point-of-sale system and enhancements
WO2015024668A2 (en) 2013-08-21 2015-02-26 Curevac Gmbh Respiratory syncytial virus (rsv) vaccine
RU2733424C2 (en) 2013-08-21 2020-10-01 Куревак Аг Method for increasing the expression of encoded rna proteins
CN105517566A (en) 2013-08-21 2016-04-20 库瑞瓦格股份公司 Composition and vaccine for treating prostate cancer
WO2015024665A1 (en) 2013-08-21 2015-02-26 Curevac Gmbh Rabies vaccine
KR20160042935A (en) 2013-08-21 2016-04-20 큐어백 아게 Composition and Vaccine for Treating Lung Cancer
CA2915730A1 (en) 2013-08-21 2015-02-26 Karl-Josef Kallen A combination rsv/influenza a vaccine
ES2806575T3 (en) 2013-11-01 2021-02-18 Curevac Ag Modified RNA with decreased immunostimulatory properties
US9956532B2 (en) * 2013-11-07 2018-05-01 U.S. Department Of Energy Apparatus and method for generating swirling flow
CN111304231A (en) 2013-12-30 2020-06-19 库瑞瓦格股份公司 Artificial nucleic acid molecules
WO2015101416A1 (en) 2013-12-30 2015-07-09 Curevac Gmbh Methods for rna analysis
CA2927254C (en) 2013-12-30 2023-10-24 Curevac Ag Artificial nucleic acid molecules
EP3110401A4 (en) 2014-02-25 2017-10-25 Merck Sharp & Dohme Corp. Lipid nanoparticle vaccine adjuvants and antigen delivery systems
JP6373749B2 (en) * 2014-12-19 2018-08-15 富士フイルム株式会社 Liposome production method and liposome production apparatus
US10035113B2 (en) * 2015-02-26 2018-07-31 Tokyo Electron Limited Method and system for a spiral mixer
EP3288671A4 (en) 2015-04-28 2019-01-16 The University Of British Columbia Disposable microfluidic cartridge
JP6925020B2 (en) 2017-03-22 2021-08-25 国立大学法人横浜国立大学 Mixing device and mixing method

Also Published As

Publication number Publication date
EP3917656A1 (en) 2021-12-08
BR112021014909A2 (en) 2021-11-23
CN113710353A (en) 2021-11-26
MX2021009236A (en) 2021-11-12
JP7545395B2 (en) 2024-09-04
AU2020214425A1 (en) 2021-08-19
WO2020160430A1 (en) 2020-08-06
KR20210133218A (en) 2021-11-05
SG11202108098QA (en) 2021-08-30
US20220126244A1 (en) 2022-04-28
CA3128488A1 (en) 2020-08-06
JP2022523117A (en) 2022-04-21

Similar Documents

Publication Publication Date Title
IL285214A (en) Vortex mixers and associated methods, systems, and apparatuses thereof
GB2587144B (en) Collaborative design systems, apparatuses, and methods
IL284748A (en) Anti-cyberbullying systems and methods
ZA202106600B (en) Apparatuses, methods, and systems for vibratory screening
EP3528716A4 (en) Osteotomy systems, devices and methods
PL3762346T3 (en) Gypsum panels, methods, and systems
GB201902215D0 (en) Flow balancing devices, methods, and systems
EP3573547C0 (en) Securement devices, systems, and methods
EP3630380A4 (en) Devices, systems, and methods for cleaning vessels
IL291299A (en) Anti-tnfr2 antibodies, composotions comprising same and uses thereof
IL262685B (en) Reagent mixing system and methods
PL3386617T3 (en) Mixing insert, static mixer and productionmethod
HK1252941A1 (en) Integrated weather projection systems, methods, and apparatuses
EP3294635A4 (en) Apparatuses, systems, and methods for dispensing condiments
EP3734035A4 (en) Scr system urea mixer and scr system
EP3716819C0 (en) Systems, methods, and apparatuses for securing deliveries
EP4061236C0 (en) Needle-guidance systems, components, and methods thereof
GB201710546D0 (en) Dialysis systems, devices and methods
EP3419898A4 (en) Flight indication apparatuses, systems and associated methods
IL289749A (en) Assay apparatuses, methods and reagents
EP3766669C0 (en) 3d-printing methods and systems
EP3448178A4 (en) User equipment, cooking apparatus, and cooking system
IL288729A (en) Devices, systems and methods for mixing and/or introducing agrochemicals
GB201801481D0 (en) Methods, conjugates and systems
GB2560910B (en) Fluid-monitoring probe, baffle and system